A. López-Pousa

发表

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study

M. Rubini, E. de Álava, J. Martín-Broto, 2016, Clinical Sarcoma Research.

The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial‐like head and neck carcinoma subtypes

R. Mangues, A. Barnadas, M. Pavón, 2019, Head & neck.

Selective depletion of metastatic stem cells as therapy for human colorectal cancer

R. Eritja, E. Vázquez, R. Mangues, 2018, EMBO molecular medicine.

CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced‐stage head and neck squamous cell carcinoma

R. Mangues, A. Barnadas, M. Pavón, 2016, Head & neck.

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

J. Bourhis, C. Borel, A. Schueler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Miguel Caballero-Borrego, P. Castillo, Pilar Navarrete, 2024, Brazilian journal of otorhinolaryngology.

Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models.

E. Vázquez, R. Mangues, A. Villaverde, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups

J. Blay, A. Italiano, A. D. Dei Tos, 2019, EClinicalMedicine.

Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma

R. Mangues, A. Barnadas, M. Pavón, 2018, Head & neck.

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

A. Antón, A. Poveda, A. Casado, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors

J. Fletcher, J. Carles, S. George, 2020, BMC Cancer.

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy

M. Arranz, A. Peiró, L. Trullols, 2022, Journal of personalized medicine.

Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A

J. Martín-Broto, A. Carnero, Marco Pérez, 2023, Signal transduction and targeted therapy.

Surgical and oncological results after surgical treatment of patients diagnosed with sarcoma liver metastases.

A. López-pousa, S. Sánchez-Cabús, A. Moral Duarte, 2022, Cirugia espanola.

SELNET Clinical practice guidelines for bone sarcoma.

R. Maki, A. D. Dei Tos, J. Martín-Broto, 2022, Critical reviews in oncology/hematology.

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

J. Mora, E. de Álava, J. Martín-Broto, 2017, British Journal of Cancer.

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, S. Bonvalot, O. Mir, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).

O. Gallego, A. Barnadas, D. Páez, 2018 .

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

J. Dopazo, E. de Álava, J. Martín-Broto, 2020, Journal for ImmunoTherapy of Cancer.

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).

J. Giralt, R. Mesía, J. Rodrigo, 2017, Oral oncology.

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

J. Carles, L. Paz-Ares, R. Hitt, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

J. Martín-Broto, C. Valverde, V. Martínez-Marín, 2022, Nature Communications.

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)

J. Martín-Broto, C. Valverde, J. López-Martín, 2017, Cancer Chemotherapy and Pharmacology.

Results from a phase II study of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients with PD-L1 unselected metastatic second-line squamous head and neck carcinoma.

I. Braña, M. Forster, M. Krebs, 2021 .

CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas

S. Bagué, I. Casanova, U. Unzueta, 2024, Diagnostics.

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

A. B. Hassan, S. Sleijfer, S. Bonvalot, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas

E. Esteban, J. Maurel, M. Gion, 2007, Cancer Chemotherapy and Pharmacology.

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

J. Maurel, A. de Juan, A. Poveda, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential dose‐dense doxorubicin and ifosfamide for advanced soft tissue sarcomas

C. Balañà, J. Maurel, A. Casado, 2004, Cancer.

Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC).

R. Hitt, H. Cortés-Funes, A. Irigoyen, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Organ Preservation in Patients With Advanced Laryngeal Tumours. Results of Induction Chemotherapy Versus Chemoradiotherapy in Actual Clinical Practice

O. Gallego, M. Quer, X. León, 2021 .

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

C. García-Girón, R. Hitt, C. Jara-Sánchez, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib

J. Blay, A. Italiano, A. Le Cesne, 2022, Cancers.